Verastem (NASDAQ:VSTM) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.43) by 18.6 percent. This is a 44.44 percent increase over losses of $(0.63) per share from the same period last year. The company reported quarterly sales of $25.078 million which beat the analyst consensus estimate of $23.093 million by 8.59 percent. This is a 1.07K percent increase over sales of $2.137 million the same period last year.